Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Jul 21;19(9):1814–1823.e1. doi: 10.1016/j.cgh.2020.07.035

Table 2:

Factors associated with the presence of lamina propria and lamina propria fibrosis in esophageal biopsies obtained from children with and without EoE

Category Factors Presence of lamina propria (N=217) Factors Presence of lamina propria fibrosis (N=123)

OR (95% CI) P value aOR (95% CI) P value OR (95% CI) P value aOR (95% CI) P value
Demographics Male 3.11 (1.74–5.54) <0.001 Male 6.51 (1.46–29.02) 0.01 8.37 (1.23–56.74) 0.03
Age 0.89 (0.83–0.95) 0.001
Clinical Antihistamines 2.13 (1.21–3.73) 0.008 Allergic rhinitis 2.29 (1.02–5.14) 0.04
Nasal topical steroids 3.03 (1.62–5.66) 0.001 Asthma 2.35 (1.03–5.35) 0.04
Abdominal pain 0.36 (0.20–0.64) 0.001 Dysphagia 3.18 (1.22–8.25) 0.01
Endoscopy Edema 3.58 (1.68–7.62) 0.001 Edema 6.44 (2.68–15.45) <0.001
Furrows 3.93 (1.94–7.94) <0.001 Exudates 4.54 (1.71–12.03) 0.002
EREFS 1.88 (1.34–2.63) <0.001 Furrows 4.90 (2.06–11.64) <0.001
EREFS 2.00 (1.43–2.79) <0.001
Histology Number of biopsies 1.25 (1.07–1.46) 0.004 Number of biopsies 1.39 (1.10–1.75) 0.005
PEC 1.02 (1.01–1.03) <0.001 PEC 1.03 (1.01–1.04) <0.001 1.02 (1.00–1.04) 0.01
Activity Active EoE 4.47 (1.88-10.63) 0.001 4.23 (1.00-18.13) 0.05 Active EoE 6.68 (1.82-24.44) 0.004

OR: Odds ratio; aOR: adjusted odds ratio; CI: confidence interval; EREFS: endoscopic reference score; PEC: peak eosinophil counts